Elicio Therapeutics
ELTX
ELTX
30 hedge funds and large institutions have $3.98M invested in Elicio Therapeutics in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
-8
Holders Change %
-21.05%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
6
Reduced
10
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
CM
CM Management
Gulf Breeze,
Florida
|
+$107K |
2 |
UBS Group
Zurich,
Switzerland
|
+$2.17K |
3 |
BlackRock
New York
|
+$966 |
4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$947 |
5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$552 |
Top Sellers
1 |
Renaissance Technologies
New York
|
-$71K |
2 |
Millennium Management
New York
|
-$40.7K |
3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$26.7K |
4 |
VFA
Valeo Financial Advisors
Carmel,
Indiana
|
-$21.7K |
5 |
E
Ergoteles
New York
|
-$21.1K |